Janny van den Eijnden-van Raaij, PhD hDMT

Janny van den Eijnden-van Raaij, PhD

Janny van den Eijnden-van Raaij, PhD hDMT

Janny van den Eijnden-van Raaij is managing director and executive board member of the Institute for human organ and Disease Model Technologies (hDMT) in The Netherlands.

She studied Biochemistry at the University of Nijmegen and received her PhD in 1985 on the thesis ‘Calcium-binding lens membrane proteins’. She pursued her career as a group leader at the Hubrecht Institute in Utrecht. Her research focused on the role of growth factor and growth factor receptors in embryonic development and tumor formation, using stem cell cultures as in vitro model system.

In 2000, Janny started at the Comprehensive Cancer Center South in Eindhoven as Chief of the Patient Care Department, and in 2003, she became the Chief Executive Officer of this Institute. Under her regime, the department of epidemiological cancer research and registry developed into a renowned international group that became European leader in this field. The numerous analyses of quality of cancer care, quality of life of cancer patients and trends and new developments in the cancer field have resulted in many new insights and improvements for cancer patients in The Netherlands and outside.

In 2014, she switched careers to set up a new Dutch Institute hDMT, which was realized in 2015. Through her work, Dr. van den Eijnden-van Raaij has built up a broad national and international network of researchers and policy makers in different areas.